Beranda › Kanker Paru › Ohio › Akron
Uji klinis Kanker Paru di Akron, OH
16 studi untuk Kanker Paru mencari peserta di lokasi sekitar Akron (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Cleveland Clinic Akron General, Akron
- Aultman Health Foundation, Canton · 21 mi jauhnya
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Summa Health System - Akron Campus, Akron
- Cleveland Clinic Akron General, Akron
- Summa Health System - Barberton Campus, Barberton · 7 mi jauhnya
- dan 1 lainnya
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Menerima pesertaFase 3
- Aultman Health Foundation, Canton · 21 mi jauhnya
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Aultman Health Foundation, Canton · 21 mi jauhnya
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
Menerima pesertaFase 3
- GSK Investigational Site, Canton · 21 mi jauhnya
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Aultman North, North Canton · 15 mi jauhnya
- Aultman Massillon, Massillon · 20 mi jauhnya
- Aultman Orrville Hospital, Orrville · 21 mi jauhnya
- dan 2 lainnya
A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)
Menerima pesertaFase 1/2
- GSK Investigational Site, Canton · 21 mi jauhnya
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Menerima pesertaFase 2/3
- Gabrail Cancer Center Research, Canton · 21 mi jauhnya
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Menerima pesertaFase 3
- Cleveland Clinic - Akron General Hematology & Oncology, Akron
- Cleveland Clinic Mercy Hospital Cancer Center, Canton · 21 mi jauhnya
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Cleveland Clinic Akron General, Akron
- Cleveland Clinic Mercy Hospital, Canton · 21 mi jauhnya
- Aultman Health Foundation, Canton · 21 mi jauhnya
Integrated Cancer Repository for Cancer Research
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Aultman Hospital, Canton · 21 mi jauhnya
- Aultman Alliance Community Hospital, Alliance · 24 mi jauhnya
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Cleveland Clinic Mercy Hospital, Canton · 21 mi jauhnya
- Aultman Health Foundation, Canton · 21 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Aultman Health Foundation, Canton · 21 mi jauhnya
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Aultman Health Foundation, Canton · 21 mi jauhnya
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Menerima pesertaStudi observasional
- Tri-County Hematology & Oncology Associates, Inc., Massillon · 20 mi jauhnya
- Cleveland Clinic Mercy Hospital, Canton · 21 mi jauhnya
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Menerima pesertaFase 1/2
- Gabrail Cancer Center Research, Canton · 21 mi jauhnya
Uji klinis Kanker Paru di kota lain
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Washington, DC41 studi
- Arlington, VA41 studi
- Chicago, IL41 studi
- Nashville, TN40 studi
- Baltimore, MD40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Studi lain di Akron
- Kanker Paru Non-Sel Kecil22 studi
- Kanker (semua jenis)13 studi
- Kanker Payudara13 studi
- Kanker Prostat9 studi
- Leukemia Mieloid Akut8 studi
- Melanoma8 studi
- Kanker Paru Sel Kecil8 studi
- Kanker Metastatik8 studi
- Kanker Kolorektal8 studi
- Penyakit Hati Steatotik7 studi
- Kanker Endometrium6 studi
- Kanker Ovarium6 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.